An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Jing Xue und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; State Key Labora…. Hauptthemen laut MEDLINE: Lipopeptides, Post-Exposure Prophylaxis, Simian Acquired Immunodeficiency Syndrome, HIV Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine, National Institutes of Health.
Abstract (Originalsprache)
LP-98 is a lipopeptide HIV fusion inhibitor showing strong treatment and pre-exposure prophylaxis efficacies in non-human primates. In this study, we further characterized its pharmacokinetics, long-lasting antiviral activity, and post-exposure prophylaxis (PEP) efficacy using 62 macaques. In cynomolgus macaques, LP-98 achieved high concentrations (Cmax) with a half-life (T1/2) of ∼31 h, and sustained an effective therapeutic concentration for two weeks post-injection. In chronically SHIVSF162P3-infected rhesus macaques (RMs), weekly or biweekly LP-98 monotherapy efficiently suppressed virus replication. In the PEP study, early LP-98 administration (weekly for 4 weeks) provided robust protection against SHIVSF162P3 infection through intrarectal and intravenous challenges. No viral DNA or replication-competent virus was detected in tissues from protected RMs, even after CD8+ T cell depletion. Transcriptomic analyses revealed the potential immunomodulatory effects of LP-98 treatment. Collectively, our results demonstrate the importance of LP-98 for HIV prevention and treatment and facilitate its current clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; State Key Laboratory of Respiratory Health and Multimorbidity, Chinese Academy of Medi…
- National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical…
- Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.
- Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong 518020, China.
- Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical…
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Chinese Academy of Medical Sciences and Peking Union Medical College
- National Natural Science Foundation of China
Zitieren
APA
Xue, J., Zhu, Y., Yang, C., Liu, X., Hou, R., Wang, W., Chong, H., Cong, Z., Zhang, J., Tong, L., Lu, J., Liu, P., Chen, T., Li, N., Wei, Q., & He, Y. (2025). An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116228
Vancouver
Xue J, Zhu Y, Yang C, Liu X, Hou R, Wang W, et al. An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116228
BibTeX
@article{Xue2025,
author = {Xue, Jing and Zhu, Yuanmei and Yang, Chenbo and Liu, Xiaosheng and Hou, Rui and Wang, Wei and Chong, Huihui and Cong, Zhe and Zhang, Jingjing and Tong, Ling and Lu, Jiahan and Liu, Peiwen and Chen, Ting and Li, Na and Wei, Qiang and He, Yuxian},
title = {An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116228}
}
EUVIMED